Evaluation of the Clinical and Economic Impact of painPRIMER in the Treatment of Low Back Pain in a Primary Care Setting



Status:Completed
Conditions:Back Pain, Back Pain
Therapuetic Areas:Musculoskeletal
Healthy:No
Age Range:18 - Any
Updated:5/5/2014
Start Date:May 2013
End Date:October 2014
Contact:Peidmont Healthcare System
Email:Frank.Cole@piedmont.org
Phone:917.288.2136

Use our guide to learn which trials are right for you!

Evaluation of the Clinical and Economic Impact of Pfizer's painPRIMER Program in the Treatment of Low Back Pain in a Primary Care Setting

To evaluate the impact of painPRIMER in a prospective six-month clinical investigation
looking at clinical outcomes, health care professional and patient satisfaction, healthcare
resource use, productivity and direct and indirect costs. The hypothesis is that early
identification of the presence of neuropathic pain and back pain related comorbidities, to
direct appropriate pharmacologic and non-pharmacologic treatment, painPRIMER would improve
patient outcomes and reduce patient cycling, inappropriate use of imaging and surgery,
thereby reducing costs and productivity loss associated with these inefficiencies.

Randomized

Inclusion Criteria:

- Those aged 18 years of age

- Presenting to a HCP with low back pain

- Able to speak, write, and understand both verbal and written English

Exclusion Criteria:

- Conditions that may impede the patient's ability to participate in painPRIMER and
complete the questionnaires, as per the HCP's discretion

- Patients presenting who have undergone surgery for back pain in the previous 12
months

- Patients with Medicare as their primary insurance
We found this trial at
1
site
Fayetteville, Georgia 30214
?
mi
from
Fayetteville, GA
Click here to add this to my saved trials